Brief: TCR² Therapeutics Announces Proposed Public Offering Of Common Stock
19/01/2021 13:13
Jan 19 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF
COMMON
STOCK
* TCR2 THERAPEUTICS INC - HAS COMMENCED AN UNDERWRITTEN
PUBLIC
OFFERING OF $125 MILLION OF SHARES OF ITS COMMON STOCK
Source text for Eikon: ID:nGNX8RY7LT
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview